Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
165,150,062
-
Share change
-
-397,025
-
Total reported value
-
$10,963,789,253
-
Put/Call ratio
-
150%
-
Price per share
-
$66.39
-
Number of holders
-
288
-
Value change
-
-$317,143
-
Number of buys
-
134
-
Number of sells
-
118
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q2 2018
As of 30 Jun 2018,
SEATTLE GENETICS INC - COM (SGEN) was held by
288 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
165,150,062 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, BAILLIE GIFFORD & CO, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Capital International Investors, Matrix Capital Management Company, LP, and GOLDMAN SACHS GROUP INC.
This page lists
288
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.